Molejon, Arkhel O.
HRN: 26-22-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2024
CEFOTAXIME 500MG (VIAL)
12/15/2024
12/22/2024
IV
160mg
Q12
Aspiration Pneumonia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes